세계 산소 절약기 시장 규모는 2024-2030년의 예측 기간 동안 연평균 5.78% 성장할 것으로 예상됩니다. 산소 절약기에 대한 수요는 주로 만성폐쇄성폐질환(COPD), 천식, 수면무호흡증과 같은 호흡기 질환의 유병률 증가에 의해 촉진되고 있습니다. 또한, 노령 인구 증가와 편리한 휴대용 산소 절약기 개발로 이어지는 기술 발전은 2024-2030년의 예측 기간 동안 시장 성장에 기여하는 주요 요인 중 일부입니다.
산소 절약기 시장 역학
2019년 '2019년 만성폐쇄성폐질환(COPD)의 세계, 지역 및 국가별 유병률과 위험요인: 체계적 검토 및 모델링 분석(Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease(COPD) in 2019: a systematic review and modeling analysis" 연구에 따르면, 2019년 만성폐쇄성폐질환의 유병률은 10.3%로, 전 세계적으로 약 3억 9,190만 건에 달할 것으로 추정됩니다. 또한 세계보건기구(WHO)(2023)는 만성폐쇄성폐질환이 2019년 전 세계적으로 323만 명의 사망자를 발생시켜 사망원인 3위를 차지했다고 밝혔습니다. 또한 세계보건기구(WHO)(2022)가 제공한 데이터에 따르면 2020년 전 세계적으로 약 221만 명의 폐암 환자가 새로 발생한 것으로 추정됩니다. 이처럼 대기 오염 증가, 흡연, 직업적 위험 등 다양한 요인으로 인한 호흡기 질환의 유병률 증가는 호흡기 질환의 관리 및 치료에 대한 수요를 창출하고 결과적으로 산소 절약기 시장의 긍정적인 성장을 가져옵니다.
또 다른 시장 성장 촉진요인은 휴대용으로 편리한 산소 절약기의 개발로 이어지는 기술 발전입니다. 휴대성이 향상됨에 따라 산소 절약 장치는 산소 요법이 필요한 환자가 이동성과 독립성을 유지할 수 있도록 돕고 있습니다. 이는 지속적인 산소 요법이 필요하지만 집에 갇혀 있거나 행동이 제한되는 것을 원하지 않는 환자들에게 특히 중요합니다. 따라서 기술 발전은 예측 기간 동안 시장 성장에 긍정적인 영향을 미칠 것입니다.
그러나 규제 당국의 엄격한 승인 과정과 개발도상국 시장에서 낮은 접근성으로 이어지는 장치와 관련된 높은 비용 등은 시장 성장을 제한할 수 있는 주요 억제요인입니다.
산소 절약기 시장 부문별 분석
산소 절약기 시장의 제품 부문에서 전자식 산소 절약기 카테고리는 2023년 시장에서 큰 수익 점유율을 차지할 것으로 추정됩니다. 이는 전자식 산소 절약기가 제공하는 다양한 이점 때문인 것으로 보입니다. 전자식 산소 절약기는 첨단 센서와 알고리즘을 사용하여 사용자의 호흡 패턴에 따라 정확하게 산소를 공급합니다. 이를 통해 산소의 효율적인 사용과 최적의 치료 효과를 보장합니다. 또한, 많은 전자식 산소 절약기는 유량, 감도 등 산소 공급 설정을 사용자 정의할 수 있습니다. 이러한 유연성을 통해 의료진은 각 환자의 특정 요구에 맞게 장비를 최적화할 수 있습니다. 또한, 전자식 산소 절약기는 일반적으로 충전식 또는 교체 가능한 배터리로 구동됩니다. 따라서 외부 전원이나 콘센트에 지속적으로 연결하지 않아도 되므로 사용자의 이동성과 편의성이 향상됩니다.
따라서, 위의 요인으로 인해 전자식 산소 절약기 카테고리는 큰 성장을 기록하여 예측 기간 동안 전체 시장의 성장을 가속할 것으로 예상됩니다.
북미가 전체 산소절약기 시장을 독점할 것으로 전망
북미가 2023년 전체 지역 중 가장 높은 점유율을 차지할 것으로 예상됩니다. 이는 만성폐쇄성폐질환(COPD), 천식, 수면무호흡증과 같은 호흡기 질환의 유병률 증가에 기인한 것으로 보입니다. 또한, 기술 발전, 고령 인구 증가, 제품 출시 및 승인 측면에서 매우 유망한 시장 존재는 북미 산소 절약기 시장의 성장에 기여하는 요인으로 작용하고 있습니다.
이 보고서는 세계 산소 절약기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 제공합니다.
Oxygen Conservers Market By Product Type (Pneumatic Oxygen Conserver, Electronic Oxygen Conserver, And Liquid Oxygen Conserving Devices), End-User (Hospitals, Clinics, Nursing Homes, Homecare, And Others), and geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disorder (copd), asthma, sleep apnea, and others
The global Oxygen Conservers market is estimated to grow at a CAGR of 5.78% during the forecast period from 2024 to 2030. The demand for Oxygen Conservers is primarily being boosted by the rising prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others. Additionally, the rising geriatric population and increasing technological advancement leading to the development of portable and convenient oxygen conserver devices are some of the key factors contributing to the growth of the Oxygen Conservers market during the forecast period from 2024-2030.
Oxygen Conservers Market Dynamics:
According to the data provided by a study "Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modeling analysis" in 2022 it was estimated that the prevalence of chronic obstructive pulmonary disease was 10.3% in the year 2019, which accounted for around 391.9 million cases, globally. Additionally, the World Health Organization 2023, stated that chronic obstructive pulmonary disease became the third leading cause of death as it led to 3.23 million deaths in the year 2019, across the globe. Further, as per the data provided by the World Health Organization 2022, it was estimated that there were around 2.21 million new cases of lung cancer in 2020, globally. Thus the rising prevalence of respiratory disorders due to various factors including increasing air pollution, tobacco smoking, and occupational risks, will create a need for the management and treatment of respiratory disorders, thus resulting in the positive growth of the Oxygen Conserver market.
Another driver for the oxygen conserver market is the rising technological advancements leading to the development of portable and convenient oxygen conserver devices. With increased portability, oxygen conserver devices allow individuals requiring oxygen therapy to maintain their mobility and independence. This is especially crucial for patients who need continuous oxygen therapy, however, they don't want to be confined to their homes or limited in their activities. Therefore, rising technological advancement will positively influence the growth of the Oxygen Conservers market during the forecast period.
However, strict regulatory approval processes by regulatory authorities and high cost associated with the device leading to low accessibility in developing nations are some of the key constraints that may limit the growth of the Oxygen Conservers market.
Oxygen Conservers Market Segment Analysis:
Oxygen Conservers Market by Product Type (Pneumatic Oxygen Conserver, Electronic Oxygen conserver, and Liquid Oxygen Conserving Devices), End-User (Hospitals, Clinics, Nursing Homes, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the Oxygen Conservers market, the Electronic Oxygen Conserver category is estimated to amass a significant revenue share in the Oxygen Conservers market in 2023. This can be attributed to the various advantages provided by Electronic Oxygen Conservers. Electronic oxygen conservers utilize advanced sensors and algorithms to deliver oxygen precisely according to the user's breathing patterns. This ensures efficient oxygen utilization and optimal therapeutic effect. Additionally, many electronic conservers allow customization of oxygen delivery settings, such as flow rate and sensitivity. This flexibility enables healthcare providers to optimize the device to the specific needs of each patient. Further, electronic conservers are typically powered by rechargeable or replaceable batteries. This eliminates the need for external power sources or continuous connection to an electrical outlet, providing greater mobility and convenience for users.
Therefore, owing to the above-mentioned factors, the Electronic Oxygen Conserver category is expected to register significant growth, thereby driving the growth of the overall Oxygen Conservers market during the forecast period.
North America Is Expected To Dominate The Overall Oxygen Conservers Market:
North America is expected to account for the highest proportion of the Oxygen Conservers Market in 2023, out of all regions. This can be attributed to the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others. Additionally, increasing technological advancements, a growing geriatric population, and the presence of a highly viable market in terms of product launches and approvals are some of the contributing factors to the growth of the Oxygen Conservers market in North America.
According to the data provided by the American Society of Cancer 2023, it was estimated that there were around 2,38,340 new cases of lung cancer in the United States in the year 2023.
Additionally, according to the data provided by the Centers for Disease Control and Prevention 2021, it was estimated that around 25 million people in the United States were suffering from asthma in the year 2021.
Thus, the rising prevalence of various respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Cancer will create a need for the management and treatment of respiratory disorders, thus resulting in the positive growth of the oxygen conservers market in the United States, which will eventually propel the oxygen conservers market in North America.
Further, key players present in the region, such as Medline Industries, Invacare corporation, Precision Medical Inc., and Sunset Healthcare Inc. are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Oxygen Conservers market in North America.
Therefore, according to the factors mentioned above, the overall market for Oxygen Conservers in North America will increase during the forecast period.
Oxygen Conservers Market Key Players:
Some of the key market players operating in the Oxygen Conservers market include Medicap Homecare GmbH, Invacare Corporation, GCE Group, Medline Industries, Inc., Precision Medical, CHAD Therapeutics, Sunset Healthcare Solution Inc., Essex Industries, Drive Medical, Drive DeVilbiss International, Roscoe Medical, HERSILL, Krober Medizintechnik GmbH, and Others.
Recent Developmental Activities In The Oxygen Conservers Market:
Key Takeaways From The Oxygen Conservers Market Report Study
Target Audience Who Can Be Benefited From This Oxygen Conservers Market Report Study
Frequently Asked Questions For The Oxygen Conservers Market:
Oxygen conservers are medical devices that are specially designed to regulate and control the flow of oxygen from an oxygen cylinder or tank to a patient's airways. They are commonly used by individuals with respiratory conditions who require supplemental oxygen therapy.
The Oxygen Conservers market is estimated to grow at a CAGR of 5.78% during the forecast period from 2024 to 2030.
The Oxygen Conservers market is slated to witness prosperity owing to factors such as the rising prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others. Additionally, the rising geriatric population and increasing technological advancement leading to the development of portable and convenient oxygen conserver devices are some of the key factors that are contributing to the growth of the Oxygen Conservers market during the forecast period from 2024-2030.
Some of the key market players operating in the Oxygen Conservers market include Medicap Homecare GmbH, Invacare Corporation, GCE Group, Medline Industries, Inc., Precision Medical, CHAD Therapeutics, Sunset Healthcare Solution Inc., Essex Industries, Drive Medical, Drive DeVilbiss International, Roscoe Medical, HERSILL, Krober Medizintechnik GmbH, and Others.
North America is expected to dominate the overall Oxygen Conservers market during the forecast period, 2024 to 2030. This can be attributed to the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others. Additionally, increasing technological advancements, a growing geriatric population, and the presence of a highly viable market in terms of product launches and approvals are some of the contributing factors to the growth of the Oxygen Conservers market in North America.